Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine.

Alicia AlpuenteVictor J GallardoLaila AsskourEdoardo CaronnaMarta Torres-FerrusPatricia Pozo-Rosich

Published in: Annals of neurology (2022)

Patients with migraine not only have higher CGRP levels compared with HCs, but also the presence of depressive symptoms seems to increase salivary CGRP levels and we have evidence, for the first time, that baseline salivary CGRP concentration is associated with treatment response to erenumab. ANN NEUROL 2022;92:846-859.

Keyphrases

depressive symptoms
combination therapy
neural network
replacement therapy